Litigation Details for iCeutica Pty Ltd. v. Novitium Pharma LLC (D. Del. 2018)
✉ Email this page to a colleague
iCeutica Pty Ltd. v. Novitium Pharma LLC (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-04-20 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | Plaintiff | Referred To | |
Patents | 9,526,734; 9,649,318; 9,808,468 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in iCeutica Pty Ltd. v. Novitium Pharma LLC
Details for iCeutica Pty Ltd. v. Novitium Pharma LLC (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-09-23 | 97 | Order - -Memorandum and Order | States Patent Nos. 9,526,734 (the "#734 patent"), 9,649,318 (the "#318 patent"),…9,808,468 (the "#468 patent"). D.I. 1 at ,r 1. The asserted patents cover Plaintiffs' VIVLODEX…10mg, before the expiration of the" asserted patents. D.I. 76 at 1. The deadline for leave to…counterclaims, seeking to assert that the asserted patents are invalid as indefinite under 35 U.S.C. ยง 112… 20 April 2018 1:18-cv-00599-CFC Patent - Abbreviated New Drug Application(ANDA) | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |